NIFTY 50
24,649.55 (-0.30%)
NIFTY IT
35,034.50 (-0.48%)
NIFTY AUTO
23,876.30 (0.37%)
NIFTY FINANCIAL SERVICES
26,373.50 (-0.39%)
NIFTY BANK
55,360.25 (-0.47%)
NIFTY REALTY
907.85 (-0.46%)
NIFTY ENERGY
34,914.40 (-0.03%)
NIFTY METAL
9,336.05 (0.09%)
NIFTY FMCG
55,733.70 (-0.72%)
NIFTY HEALTH CARE
14,481.55 (-0.48%)
NIFTY PHARMA
21,970.15 (-0.83%)
NIFTY MEDIA
21,970.15 (-0.83%)
Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Zydus Lifesciences Ltd

  • Share Price :
  • 960.25
  • 1.40(0.15%)
Zydus Lifesciences Ltd (NSE)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y

1.40(0.15%)

960.25
Open
953.50		 Prev. Close
958.85
Price
960.25		 Value
4,607.62
52 week high
1,324.30		 52 week low
795.00
Today’s high
964.20		 Today’s low
948.10
Volume
479,835		 ISIN
INE010B01027

Zydus Lifesciences Ltd Ltd

  • Sector : Pharmaceuticals
  • MCAP : 96568.28 Crore
Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022. The Company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products. The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raiga
More

Zydus Lifesciences Ltd Share Price History

Date Open Close Low High
05-Aug-2025 953.50 960.25 948.10 964.20
04-Aug-2025 949.95 958.85 946.55 962.00
01-Aug-2025 970.00 949.05 946.35 970.75
31-Jul-2025 975.05 969.80 961.10 986.45
30-Jul-2025 998.00 995.15 989.10 1,000.20

Share Holding

Total Foreign

Total Institutions

Total Govt Holding

Total Non Promoter Corporate Holding

Total Promoters

Total Public & others

Corporate Actions

Announcement Date Ex Dividend Date Dividends (%) Dividend Type
19-May-2025 25-Jul-2025 1100 Final
17-May-2024 26-Jul-2024 300 Final
18-May-2023 28-Jul-2023 600 Final
20-May-2022 28-Jul-2022 250 Final
27-May-2021 28-Jul-2021 350 Final

Peer Comparison

Company Name LTP Market Cap Prev. Close Change (%) 52 Week
High-Low (₹) 		Todays
High-Low (₹) 		PE (TTM) PB (₹) Dividend Yield (%)
Sun Pharmaceuti... 1,632.10 391,595.46 1,641.60 -0.58 1,960.35 - 1,553.05 1,644.60 - 1,620.10 81.61 16.09 0.98
Cipla Ltd 1,499.80 121,146.53 1,515.10 -1.01 1,702.05 - 1,335.00 1,517.30 - 1,491.10 22.41 3.77 1.07
Mankind Pharma ... 2,618.90 108,089.53 2,628.90 -0.38 3,054.80 - 1,901.05 2,661.50 - 2,581.60 58.65 7.38 0.00
Dr Reddys Labor... 1,214.80 101,384.99 1,225.00 -0.83 1,421.49 - 1,020.00 1,232.00 - 1,205.00 14.70 3.51 0.66
Lupin Ltd 1,864.50 85,160.54 1,882.20 -0.94 2,402.90 - 1,795.20 1,890.90 - 1,855.60 21.42 3.51 0.64
Aurobindo Pharm... 1,079.30 63,240.35 1,090.40 -1.02 1,592.00 - 1,010.00 1,109.40 - 1,060.90 32.01 3.08 0.00
Alkem Laborator... 4,921.00 58,837.94 4,902.50 0.38 6,439.90 - 4,491.65 4,932.00 - 4,853.00 25.78 4.77 0.92
Glenmark Pharma... 2,052.60 57,924.54 2,074.90 -1.07 2,284.80 - 1,275.50 2,077.80 - 2,031.50 35.95 2.36 0.12
Biocon Ltd 372.35 49,781.84 382.40 -2.63 406.00 - 291.00 386.80 - 370.65 81.70 3.11 0.12
Laurus Labs Ltd 857.50 46,289.99 861.20 -0.43 922.50 - 417.70 872.00 - 852.30 90.82 10.14 0.14
Anthem Bioscien... 736.70 41,373.81 752.30 -2.07 801.85 - 701.90 762.00 - 734.00 81.68 16.71 0.00
Cohance Lifesci... 961.60 36,787.66 958.50 0.32 1,360.00 - 915.75 980.00 - 951.00 135.35 15.79 0.00

Company News

More
About INVES 21
Insights

S A Artha Securities Private Limited,
CIN: U65900TG2022PTC167512.
Registered Office: Flat No.202A, La Paloma Caves, Road No 12, Banjara Hills, Hyderabad, Telangana- 500034,
Correspondence Office: 8-2-269/S/91/B, Sagar Society, Road No.2, Banjara Hills,Banjara Hills,HYDERABAD,500034
Tel No: 040-48444546.
SEBI Reg. No: NSE: INZ000316838 | BSE Member Code: 6902 | SEBI Reg. No: Research Analyst: INH000016667 | Mutual Fund Distributor: AMFI Reg. No ARN- 279815
SEBI Reg. No: Depository Participant (NSDL): IN-DP-776-2024 | Member: NSE - TM Code-90369.

Details of Client Bank Account
For any query / feedback / clarification, email at info@inves21.com

In case of grievance for any of the services rendered by S A Artha Securities Private Limited, please write to grievance@inves21.com (for NSE). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms & Conditions, and Privacy Policy. Compliance Officer: Mahananda Samsani, E-mail address: compliance@inves21.com. To lodge your complaints using SEBI SCORES, Click here.

Procedure to file a complaint on SEBI SCORES:
- Register on SCORES portal.
- Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID.
- Benefits: Effective Communication, Speedy redressal of grievances.

Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit.

Attention investors:

  • Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w. e. f. September 01, 2020   
  • Update your e-mail and phone number with your stock broker/ depository participant and receive OTP directly from the depository on your e-mail and / or mobile number to create a pledge.
  • Check your securities/ MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: To prevent unauthorized transactions in your account. Update your mobile number/email IDs with your stock brokers. Receive information on your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets. Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach an intermediary. “Dear investor, if you are subscribing to an IPO, there is no need to issue a cheque. Please write the bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non-allotment, the funds will remain in your bank account.
S A Artha Securities Private Limited is a distributor of Mutual funds. Mutual fund investments are subject to market risks, and all disputes with respect to the distribution activity would not have access to the Exchange investor redressal forum or Arbitration mechanism. Please read all scheme-related documents carefully before investing. The past performance of the schemes is neither an indicator nor a guarantee of future performance.
Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: NSE

Kindly read the Advisory Guidelines of NSE for investors as prescribed by the exchange with reference to their circular dated 27th August 2021 regarding investor awareness and safeguarding client’s assets.

  • Copyright © 2024   INVES 21
  • Designed, developed and Content Provide by CMOTS Infotech (ISO 9001:2015 certified)